Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.518
https://www.valueinhealthjournal.com/article/S1098-3015(17)30852-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
487
First Page :
A490
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30852-5&doi=10.1016/j.jval.2017.08.518